NSIM
UTHR icon

North Star Investment Management’s United Therapeutics UTHR Stock Holding History

North Star Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Hold
201
– – 0.01% 593
2026
Q1 		$119K Sell
201
-7
-3% -$3.49K 0.01% 575
2025
Q4 		$101K Buy
208
+8
+4% +$3.73K 0.01% 550
2025
Q3 		$83.8K Hold
200
– – 0.01% 561
2025
Q2 		$57.5K Hold
200
– – ﹤0.01% 606
2025
Q1 		$61.7K Hold
200
– – ﹤0.01% 581
2024
Q4 		$70.6K Hold
200
– – ﹤0.01% 565
2024
Q3 		$71.7K Hold
200
– – 0.01% 549
2024
Q2 		$63.7K Hold
200
– – ﹤0.01% 560
2024
Q1 		$45.9K Hold
200
– – ﹤0.01% 623
2023
Q4 		$44K Hold
200
– – ﹤0.01% 609
2023
Q3 		$45.2K Buy
+200
New +$46.1K ﹤0.01% 604

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

North Star Investment Management's UTHR Position: Q2 2026 in Review

North Star Investment Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 201 shares worth $109K. The position accounts for 0.01% of the portfolio, ranked #593.

North Star Investment Management first reported a position in UTHR in Q3 2023 and has held it in 12 quarters since. The position peaked at $119K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • North Star Investment Management held 201 shares of United Therapeutics worth $109K as of Q2 2026.
  • North Star Investment Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.01% of North Star Investment Management's portfolio in Q2 2026, its #593 holding.
  • North Star Investment Management first reported a position in United Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • North Star Investment Management's United Therapeutics position peaked at $119K in Q1 2026.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.